Brand shuffling of traditional Chinese medicine injection industry

On the one hand is the rapid expansion of the market scale, on the other hand is the seemingly ambiguous but actually evasive attitude of major hospitals - traditional Chinese medicine injection is facing an embarrassing situation Data shows that the compound growth rate of traditional Chinese medicine injection in recent five years is about 21%, which is significantly higher than the growth rate of the whole drug market According to the data released by the State Food and drug administration, more than 100000 adverse reactions of traditional Chinese medicine injections were detected in the whole year last year, and the safety of traditional Chinese medicine injections was once again questioned The message from the policy level is tighter regulation It is reported that the 2015 edition of China Pharmacopoeia, which has entered the revision procedure, also strengthens the supervision and control of traditional Chinese medicine injection In the purchase orders of basic drugs in Inner Mongolia and other regions, the proportion of traditional Chinese medicine injection once dropped significantly, while Zhejiang province directly said no to traditional Chinese medicine injection Some people predict that about 60% of traditional Chinese medicine injections will be delisted gradually in the future, and many traditional Chinese medicine injection manufacturers will face the risk of bankruptcy According to the public data of important performance sources of listed companies, the number of drugs produced by domestic pharmaceutical companies is up to 160000, and the number of traditional Chinese medicine is close to 60000, while the number of traditional Chinese medicine injections is no more than 140 There are more than 50 kinds of commonly used traditional Chinese medicine injections, and only about 150 pharmaceutical companies are engaged in the production of traditional Chinese medicine injections However, although there are not many kinds of traditional Chinese medicine injections, they have become the largest market share in the field of traditional Chinese medicine The overall market size is 25 billion-30 billion yuan, with a compound growth rate of about 21% in the past five years, which is significantly higher than the growth rate of 15.78% of traditional Chinese medicine and 18.23% of the whole drug market In particular, it is worth noting that traditional Chinese medicine injection is the top one in the market of cardio cerebrovascular and anti-tumor Chinese patent medicine, with 7 products ranking in the top 10 in the market share This makes a large number of Chinese medicine listed companies taste the sweetness Chinese medicine injection once became the leader in promoting the performance of listed companies According to the 2013 China Daily, Shanghai Kaibao (300039, Guba) Chinese medicine injection accounted for 99% of the total revenue, and became the most concentrated enterprise in the industry Zhongheng group (600252, Guba) also accounted for 88% of the total revenue In HongRi Pharmaceutical (300026, Guba) and Kangyuan pharmaceutical (600557, Guba), the data also reached 64% and 55% Li Xihuan, an analyst in Xinda securities industry, analyzed in the research report that the market scale of traditional Chinese medicine injection has reached 30 billion yuan at present, and large varieties have become cash cows of enterprises In fact, traditional Chinese medicine injection has only 60 years of history, and was once regarded as the innovative medicine of the modernization of traditional Chinese medicine However, compared with the rapidly expanding market scale, the safety of traditional Chinese medicine injection has been questioned According to the data released by the State Food and drug administration, in 2012, the national ADR monitoring network received 103 thousand reports of 14 large categories of traditional Chinese medicine injections, an increase of 58.2% over the same period in 2011, including more than 5500 serious reports, accounting for 5.3% However, according to Zhang Boli, academician of the Chinese Academy of engineering, the occurrence of adverse reactions also has a lot to do with personal physique, infusion speed and unreasonable use of drugs by doctors, among which unreasonable drug compatibility can increase the incidence of adverse reactions by 40% In fact, the doubt of the safety nature of traditional Chinese medicine injection not only exists in the medical industry, but also the government departments have begun to strengthen the supervision of traditional Chinese medicine injection As early as may last year, about 30 kinds of traditional Chinese medicine injections were shut down successively; six months later, the State Food and Drug Administration eliminated 11 kinds of traditional Chinese medicine injections, including chaixin Ganmao injection, on the grounds of less clinical use, insufficient safety and effectiveness data In March this year, the State Food and Drug Administration launched an inspection on 13 varieties of Shenmai injection, Shuanghuanglian injection and Chaihu Injection According to Zhou Fucheng, deputy secretary-general of the national pharmacopoeia commission, we should further strengthen the safety control of high-risk traditional Chinese medicine injection, and study and establish a new method for the examination of abnormal toxicity, allergic reaction, polymer, protein, resin and other related substances of traditional Chinese medicine injection In addition, some local governments tend to be cautious about the centralized procurement of basic drugs In Inner Mongolia, for example, the proportion of traditional Chinese medicine injections purchased in June fell by 40% Recently, the Department of health of Zhejiang Province issued a notice to supplement the varieties of traditional Chinese medicine injections, but clearly pointed out that traditional Chinese medicine injections were not supplemented.